Ben Goldacre makes a strong case for not using placebo. If there's already a widely used alternative, surely they should test against the best currently availab

Ben Goldacre makes a strong case for not using placebo. If there's already a widely used alternative, surely they should test against the best currently available treatment, instead of testing against nothing (placebo). The more concerning point Goldacre raises is that unflattering trial data goes missing, and this is completely ok with the FDA.